A2 Adenosine Receptors and Vascular Pathologies

被引:32
作者
Johnston-Cox, Hillary A.
Koupenova, Milka [2 ]
Ravid, Katya [1 ,2 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Evans Ctr Interdisciplinary Biomed Res,CVI, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Biochem, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
基金
美国国家卫生研究院;
关键词
macrophages; restenosis; signal transduction; thrombosis; adenosine; SMOOTH-MUSCLE-CELLS; PROTEIN-COUPLED RECEPTORS; TNF-ALPHA PRODUCTION; NUCLEOSIDE TRANSPORTER FAMILY; HUMAN ATHEROSCLEROTIC PLAQUES; MOUSE PERITONEAL-MACROPHAGES; LUMINAL CORONARY ANGIOPLASTY; E-DEFICIENT MICE; A(2B) RECEPTORS; A(2A) RECEPTOR;
D O I
10.1161/ATVBAHA.112.246181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease, a leading cause of death and morbidity, is regulated, among various factors, by inflammation. The level of the metabolite adenosine is augmented under stress, including inflammatory, hypoxic, or injurious events. Adenosine has been shown to affect various physiological and pathological processes, largely through 1 or more of its 4 types of receptors: the A1 and A3 adenylyl cyclase inhibitory receptors and the A2A and A2B adenylyl cyclase stimulatory receptors. This article focuses on reviewing common and distinct effects of the 2 A2-type adenosine receptors on vascular disease and the mechanisms involved. Understanding the pathogenesis of vascular disease mediated by these receptors is important to the development of therapeutics and to the prevention and management of disease. (Arterioscler Thromb Vasc Biol. 2012; 32: 870-878.)
引用
收藏
页码:870 / 878
页数:9
相关论文
共 145 条
[81]   Cardiac myocyte adenosine receptors and caveolae [J].
Lasley, RD ;
Smart, EJ .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (07) :259-263
[82]   Adenosine in the central nervous system: release mechanisms and extracellular concentrations [J].
Latini, S ;
Pedata, F .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (03) :463-484
[83]   Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules [J].
Lazarowski, ER ;
Boucher, RC ;
Harden, TK .
MOLECULAR PHARMACOLOGY, 2003, 64 (04) :785-795
[84]   Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor [J].
Ledent, C ;
Vaugeois, JM ;
Schiffmann, SN ;
Pedrazzini, T ;
ElYacoubi, M ;
Vanderhaeghen, JJ ;
Costentin, J ;
Heath, JK ;
Vassart, G ;
Parmentier, M .
NATURE, 1997, 388 (6643) :674-678
[85]   INHIBITION OF HUMAN MONOCYTE TNF PRODUCTION BY ADENOSINE RECEPTOR AGONISTS [J].
LEVRAUX, V ;
CHEN, YL ;
MASSON, I ;
DESOUSA, M ;
GIROUD, JP ;
FLORENTIN, I ;
CHAUVELOTMOACHON, L .
LIFE SCIENCES, 1993, 52 (24) :1917-1924
[86]   Signaling During Platelet Adhesion and Activation [J].
Li, Zhenyu ;
Delaney, M. Keegan ;
O'Brien, Kelly A. ;
Du, Xiaoping .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (12) :2341-2349
[87]   Adenosine in tissue protection and tissue regeneration [J].
Linden, J .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1385-1387
[88]   Molecular approach to adenosine receptors: Receptor-mediated mechanisms of tissue protection [J].
Linden, J .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :775-787
[89]   Effect of adenosine A2 receptor stimulation on platelet activation-aggregation:: Differences between canine and human models [J].
Linden, Matthew D. ;
Barnard, Marc R. ;
Frelinger, A. L. ;
Michelson, Alan D. ;
Przykienk, Karin .
THROMBOSIS RESEARCH, 2008, 121 (05) :689-698
[90]   Thrombin receptor antagonism -the potential of antiplatelet medication SCH 530348 [J].
Macaulay, Tracy E. ;
Allen, Christopher ;
Ziada, Khaled M. .
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (06) :1015-1022